Press Release

CD BIOSCIENCES LAUNCHES NEW SOLUTIONS FOR TYPE III CELL DEATH RESEARCH



CD BioSciences has recently launched a suite of research solutions to assist researchers in the study of Type III cell death.

FOR IMMEDIATE RELEASE

07/07/2023

CD BioSciences, a US-based CRO serving the global life science research community, has recently launched a suite of research solutions to assist researchers in the study of Type III cell death, including Regulator Characterization, Regulator Identification, Mechanism Study, and Phenotype Analysis.

Cell death, survival, proliferation and differentiation are the fundamental processes of life. Cell death plays a key role in embryonic development, maintaining the homeostasis of the organism and eliminating damaged cells. It was originally classified into three types (1): type I cell death (apoptosis), type II cell death (autophagy), and type III cell death (necrosis). All three types can be executed by different, sometimes overlapping, signaling pathways that respond to specific stimuli.

Necrosis is characterized by cell swelling, plasma membrane rupture, and loss of organelle structures without chromatin cohesion. Although necrosis can occur as a result of irreparable cellular damage, there is at least one pathway of active necrosis. This form of cell death involves several signaling pathways, all of which center on the activation of receptor-interacting protein kinase 3 (RIP3), which is activated upon recruitment to macromolecular complexes downstream of various cell surface receptors: DRs, Toll-like receptors (TLRs), and T-cell receptors (TCRs).

In addition, DNA damage can directly induce the formation of RIP3 activation platforms independent of cell surface receptor binding. Finally, RIP3-dependent necrosis is also triggered by cell membrane DNA sensors, DNA-dependent activator of interferon (DAI) regulatory factors following viral infection, and the presence of double-stranded viral DNA in the cell membrane.

As a trusted CRO, CD Biosciences offers comprehensive solutions for all aspects of life science research, particularly type III cell death. These death research solutions include, but are not limited to the following:

(1)Regulator Identification, identifying gene regulators involved in cell death signaling pathways.
(2)Regulator Characterization, studying the molecular function of a certain regulator in cell death signaling pathways.
(3)Mechanism Study, investigating the regulatory mechanisms of specific regulators.
(4)Phenotype Analysis, analyzing cellular phenotypes regulated by the gene/protein of interest.
(5)Cell Death Characterization, identifying and characterizing the types of cell death under certain conditions.

CD Biosciences is dedicated to meeting all the needs of researchers in signaling pathway research and can support customers' innovative discoveries by providing high-quality reagents and comprehensive solutions. If you're interested in learning more about cell death solutions or other signaling pathways, please visit CD BioSciences at https://www.cd-biosciences.com/.

About CD BioSciences

CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is a one-stop shop devoted to advancing signaling pathway studies for researchers. The company is committed to fulfilling all demands in the research of signaling pathways and provides high-quality reagents and comprehensive solutions to support innovative discoveries.

Tags:
Type III cell death  |  CD BioSciences  |  

---

Organisation Profile:
CD BioSciences is a trusted research product supplier and CRO based in New York. With high-quality reagents and comprehensive services, CD BioSciences is the one-stop shop devoted to researchers making advancements in signaling pathway studies.






Press release contact details for CD BioSciences

NameCD BioSciences
Tel
Fax
Email
Websitehttps://www.cd-biosciences.com/
OrganisationCD BioSciences
Address
Town
County
Postcode




Other press releases from CD BioSciences

CD BioSciences Introduces New Solutions to Support Cell Death Studies
CD BioSciences Launches Scaffold-Based Technologies for 3D Cell Culture
CD BioSciences Launches Hyperspectral Imaging Technology for Food Safety
CD BioSciences Introduces New Cell Death Solutions to Facilitate Research
CD BioSciences Launches Fluorescence Correlation Spectroscopy
CD BioSciences Introduces Various Solutions for Studying Apoptotic Cell Death
CD BioSciences Launches Nanoparticles Imaging Technology for Scientists
CD BioSciences Introduces Multiple Solutions for Type II Cell Death Research
CD BioSciences Launches New Time-Lapse Imaging Services for Scientists
CD BioSciences Launches New Solutions for Microautophagy Research
CD BioSciences Announces New Immunofluorescence-Based Services
CD BioSciences Launches New Solutions for Type III Cell Death Research
CD BioSciences Launches New Super-Resolution Imaging Technology for Biomedical Research
CD BioSciences Announces New Research Solutions on Mitotic Catastrophe
CD BioSciences Announces New Single Molecule Fluorescence Imaging Technology
CD BioSciences Introduces New Metabolic Homeostasis Research Solutions
CD BioSciences Launches New Services to Study Catabolism in Diabetes
CD BioSciences Launches New 3D Tissue Imaging Services
HighRun DataScience Launches Data Science Platform for Global Customers
CD BioSciences Announces New Solutions for Studying Anabolism
CD Biosciences Introduces 3D Image Analysis Services For Bioimaging Research
CD BioSciences Expands Portfolio with Wide Range of Embedding Resins and Kits for Electron and Light Microscopy
CD BioSciences Announces New Solutions for Glucose Homeostasis Research
CD Biosciences Announces Expanded Capabilities for Mechanistic Target of Rapamycin Research in Diabetes and Metabolism
CD Biosciences Launches Substrate-Chromogens for Immunohistochemistry
CD BioSciences Launches New Range of In Vivo Imaging Reagents for Scientific Research
CD BioSciences Introduces IHC Ancillaries for Enhanced Research and Diagnostics
CD BioSciences Announces Comprehensive Range of Nervous System Tissue Microarrays

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.